Blog | BioInformant

Unicyte and Collaboration Partner Prof. Camussi Achieve Preclinical Milestone in Diabetes Program

September 18, 2018 By Cade Hildreth, Founder & President Leave a Comment

Unicyte, a regenerative medicine unit of Fresenius Medical Care, and its collaboration partner Professor Camussi have published results in Stem Cell Reviews and Reports that a potential therapeutic strategy for diabetes is the transplantation of induced-insulin secreting cells.

The Global Disease Burden of Diabetes Mellitus

Diabetes mellitus is one of the most common diseases globally. Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. With an aging population and surging rates of obesity, the incidence of this debilitating disease on the rise. [Read more…]

Stem Cell Therapy in India – ReeLabs into Diabetes Clinical Trial

September 17, 2018 By Cade Hildreth, Founder & President 1 Comment

Stem cell therapy in India is emerging as a new modality within the healthcare system. The progress is supported by numerous innovators within the country. One company forging the way is ReeLabs, a leading stem cell bank in India that is supporting the collection and storage of stem cells, as well as the development of novel stem cell therapeutics.

Diabetes Mellitus in India

According to the World Health Organization (WHO), diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Diabetes mellitus is one of the most common diseases globally.

In India, the prevalence of diabetes is rising, predominantly related to factors such as genetic factors, stress, diet, obesity, lack of meaningful exercise and lifestyle related issues. [Read more…]

Maximum Signaling for Maximum Regeneration – Using Four Material RICHGEN Flowable Allograft

September 17, 2018 By Cade Hildreth, Founder & President 1 Comment

It’s the newest breakthrough in regenerative medicine: Using cytokine, growth factors and intracellular miRNA signaling with bio-scaffold from the extra cellular matrix components utilizing minimally-manipulated placental tissue materials. It is NOT about cell counts. It is about increasing the amplitude of signaling from the initial and continued inflammatory (injury) to the individual cell signaling pathway utilized to repair or regenerate the cellular structure that has been injured, diseased, or traumatized. [Read more…]

Stem Cells for Heart Failure? BioCardia’s CardiAMP Pairs Cells, Devices and Diagnostics

September 14, 2018 By Cade Hildreth, Founder & President 1 Comment

Circulation Research, the official journal of the American Heart Association, has highlighted a novel stem cell therapy approach developed by BioCardia. For those not familiar with BioCardia, the company specializes in developing regenerative biologic therapies to treat cardiovascular disease.

BioCardia has developed a stem cell technology that includes a novel method of administration, as well as a pre-procedure assay to achieve a comprehensive approach to heart failure. BioCardia’s CardiAMP and CardiALLO cell therapies are the Company’s biotherapeutic product candidates in clinical development.

In addition to providing Phase III 10-patient roll-incohort data for BioCardia’s CardiAMP device, the paper published by Circulation Research offers a comprehensive rationale of CardiAMP’s development as a treatment for heart failure. [Read more…]

Introducing WellSky — A New Approach to Health and Community Care

September 12, 2018 By Cade Hildreth, Founder & President Leave a Comment

Mediware Information Systems, Kinnser Software, and More Than 30 Leaders in Health IT Unite Under One New Brand, Providing Integrated Health and Community Care Solutions for Millions of Patients

Sept 11, 2018, Lenexa, Kan. — Mediware Information Systems, Inc., a portfolio company of TPG Capital, today announced its strategic transformation to WellSky, effectively merging more than 30 unique health care and human services brands. The name “WellSky” conveys both the company’s vision to elevate the quality of care through innovation and the breadth of its offerings across the continuum of care, including leading solutions and services for blood banks, home health agencies, hospices, rehab facilities, Area Agencies on Aging, and many others. [Read more…]